Načítá se...
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
Epilepsy is a common disease with significant morbidity and mortality. Approximately one-third of patients with epilepsy are refractory to available seizure medications, emphasizing the need to develop better drugs with novel mechanisms of action. Ezogabine, also known as retigabine, is a new potent...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3140293/ https://ncbi.nlm.nih.gov/pubmed/21792307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S14208 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|